Skip to main content

What the FDA labels say about taking them together

Buprenorphine and butorphanol

Buprenorphine's FDA label (Butrans) of May 1, 2026 names butorphanol in its drug interactions section; the butorphanol label PlainMeds reads does not name buprenorphine. The buprenorphine label: “May reduce the analgesic effect of BUTRANS and/or precipitate withdrawal symptoms.”

Check it at the source: the buprenorphine FDA label on DailyMed (effective June 5, 2026); the butorphanol FDA label on DailyMed (effective January 2, 2026, Hospira, Inc.).

What does the buprenorphine label say about butorphanol?

Butrans label (Knoa Pharma LLC, May 1, 2026), drug interactions

Clinical Impact: May reduce the analgesic effect of BUTRANS and/or precipitate withdrawal symptoms. Intervention: Avoid concomitant use. Examples: butorphanol, nalbuphine, pentazocine Muscle Relaxants

Source: FDA drug label (Butrans, NDA021306), Knoa Pharma LLC, effective May 1, 2026 (SPL set 794aa355-66de-41b8-aedf-f2c40f6bc664), via openFDA

Source: FDA drug label (Buprenorphine HCl), SpecGx LLC, effective June 5, 2026 (SPL set b60d514d-a88a-4fa2-a5b0-30ac29e04973), via openFDA; the full label on DailyMed

What does the butorphanol label say about buprenorphine?

Butorphanol's label (effective January 2, 2026) does not name buprenorphine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Butorphanol Tartrate), Hospira, Inc., effective January 2, 2026 (SPL set 9822ca3f-aee2-46e5-8a96-495400e65d10), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

27Buprenorphine generic labelers
4Butorphanol generic labelers
BuprenorphineButorphanol
Labeled forOpioid use disorder, PainPain
Boxed warningNoYes
Pharmacy cost (NADAC)$0.277 per tablet 2 mg tablet sl$15.46 per mL 10 mg/mL spray
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?